Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders
Clinical trial NCT03315897 · COMPLETED
Trial details
- NCT number
- NCT03315897
- Sponsor
- Lars Vedel Kessing
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2022-10-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.